GI
IONS icon

GAMMA Investing’s Ionis Pharmaceuticals IONS Stock Holding History

GAMMA Investing’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$78.7K Sell
1,763
-405
-19% -$23K ﹤0.01% 2048
2026
Q2 		$172K Buy
2,168
+402
+23% +$30.3K 0.01% 1382
2026
Q1 		$133K Buy
1,766
+33
+2% +$2.6K 0.01% 1438
2025
Q4 		$137K Buy
1,733
+392
+29% +$29.5K 0.01% 1338
2025
Q3 		$87.7K Buy
1,341
+411
+44% +$20.1K ﹤0.01% 1594
2025
Q2 		$36.7K Sell
930
-31
-3% -$1.01K ﹤0.01% 2112
2025
Q1 		$29K Buy
961
+215
+29% +$7.04K ﹤0.01% 2178
2024
Q4 		$26.1K Buy
746
+82
+12% +$3.06K ﹤0.01% 2123
2024
Q3 		$26.6K Buy
664
+303
+84% +$14.1K ﹤0.01% 1931
2024
Q2 		$17.2K Sell
361
-251
-41% -$10.3K ﹤0.01% 1951
2024
Q1 		$26.5K Buy
612
+112
+22% +$5.34K 0.01% 1446
2023
Q4 		$25.7K Buy
+500
New +$23.9K 0.01% 1328

Other funds holding IONS

WPC
Wedmont Private Capital West Chester, Pennsylvania $4.18B AUM 18.65% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
TC
Trust Company Manhattan, Kansas $1.15B AUM 7.83% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
CI
CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return
PS
Planning Strategies Lancaster, Pennsylvania $169M AUM
GWM
Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return

GAMMA Investing's IONS Position: Q3 2026 in Review

GAMMA Investing reduced its Ionis Pharmaceuticals (IONS) stake by 19% in Q3 2026, selling an estimated $23K and leaving 1,763 shares worth $78.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2048.

GAMMA Investing first reported a position in IONS in Q4 2023 and has held it in 12 quarters since. The position peaked at $172K in Q2 2026. 11 funds tracked by Wall St. Rank hold IONS as of Q3 2026.

  • GAMMA Investing held 1,763 shares of Ionis Pharmaceuticals worth $78.7K as of Q3 2026.
  • GAMMA Investing sold 405 Ionis Pharmaceuticals shares in Q3 2026, an estimated $23K.
  • Ionis Pharmaceuticals made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #2048 holding.
  • GAMMA Investing first reported a position in Ionis Pharmaceuticals in Q4 2023 and has held it in 12 quarters since.
  • GAMMA Investing's Ionis Pharmaceuticals position peaked at $172K in Q2 2026.
  • 11 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.